IONIS PHARMACEUTICALS INC
531 institutions still hold IONIS PHARMACEUTICALS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
In contrast to Q1 2026 when domestic wealth manager Davenport & Co LLC single-handedly anchored institutional volume in Ionis Pharmaceuticals Inc (IONS), Q2 2026 witnessed a surge in broad international institutional buying. Swedbank AB executed the quarter's largest buy-side move, deploying $5.03 million in net inflows to expand its holding to $7.59 million (95,666 shares). Quantitative firm Y-Intercept (Hong Kong) Ltd established a new $5.34 million stake (67,374 shares), while Davenport & Co expanded its #1 position by adding $3.63 million in net flow to reach $22.51 million (283,960 shares, 35.37% of reported 13F capital). Across 71 tracked filers, total institutional value reached $63.66 million.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.